Eli Lil­ly, the most talked-about phar­ma­ceu­ti­cal com­pa­ny in re­cent years, is buy­ing can­cer start­up Scor­pi­on Ther­a­peu­tics about half a year af­ter its ...

Around the world, public healthcare systems have struggled to reset post-pandemic, and in particular, the increasingly aged populations in Western countries are putting pressure on services, not ...